Support and unmet needs of patients undergoing multidrug-resistant tuberculosis (MDR-TB) treatment in southern Nigeria.

Autor: Oshi D; Department of Community Health and Psychiatry, University of West Indies, Mona, Jamaica.; German Leprosy and TB Relief Association, Enugu, Nigeria., Chukwu J; German Leprosy and TB Relief Association, Enugu, Nigeria., Nwafor C; German Leprosy and TB Relief Association, Enugu, Nigeria., Chukwu NE; Department of Social Work, Faculty of Social Sciences, University of Nigeria, Nsukka, Nigeria., Meka AO; German Leprosy and TB Relief Association, Enugu, Nigeria., Anyim M; German Leprosy and TB Relief Association, Enugu, Nigeria., Ukwaja KN; Department of Internal Medicine, Alex Ekwueme Federal Teaching Hospital (AE-FETHA), Abakaliki, Nigeria., Alobu I; Ebonyi State Tuberculosis and Leprosy Control Programme, State Ministry of Health, Abakaliki, Nigeria., Ekeke N; German Leprosy and TB Relief Association, Enugu, Nigeria., Oshi SN; Centre for Development and Reproductive Health, Enugu, Nigeria.
Jazyk: angličtina
Zdroj: The International journal of health planning and management [Int J Health Plann Manage] 2020 Jul; Vol. 35 (4), pp. 832-842. Date of Electronic Publication: 2019 Dec 18.
DOI: 10.1002/hpm.2929
Abstrakt: Multidrug-resistant tuberculosis (MDR-TB) is presently a major public health threat. MDR-TB patients face diverse financial and psychosocial difficulties. Researchers conducted in-depth interviews based on interview guides with 42 participants. Data were analyzed using categorization, coding, generation of themes, and thematic memo writing. The key findings were as follows: Out of the 42 patients, 30 (71.4%) were males and 12 (28.6%) were females. All patients received financial stipends for transport and monthly social support. The patients however needed more financial support than they received (suggesting high unmet financial needs). Patients suffered depressive mood before and during treatment but received inadequate mental health/psychosocial care and treatment. Patients developed hearing impairment as a major adverse drug reaction, but the care and treatment they received were inadequate. In conclusion, the programmatic support provided for MDR-TB patients' financial and mental health/psychosocial needs and auditory drug side effects fell short of their need. Programmes for control of MDR-TB should increase budgetary allocations and ramp up mechanisms for provision of mental health/psychosocial support and care/treatment for drug side effects.
(© 2019 John Wiley & Sons, Ltd.)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje